Aileron Therapeutics Stock Price To Sales
| ALRNDelisted Stock | USD 2.11 0.15 7.65% |
Aileron Therapeutics fundamentals help investors to digest information that contributes to Aileron Therapeutics' financial success or failures. It also enables traders to predict the movement of Aileron Stock. The fundamental analysis module provides a way to measure Aileron Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aileron Therapeutics stock.
Aileron |
Aileron Therapeutics Company Price To Sales Analysis
Aileron Therapeutics' Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Aileron Therapeutics has a Price To Sales of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The price to sales for all United States stocks is 100.0% higher than that of the company.
Aileron Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aileron Therapeutics' direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aileron Therapeutics could also be used in its relative valuation, which is a method of valuing Aileron Therapeutics by comparing valuation metrics of similar companies.Aileron Therapeutics is currently under evaluation in price to sales category among its peers.
Aileron Fundamentals
| Return On Equity | -0.44 | ||||
| Return On Asset | -0.26 | ||||
| Current Valuation | 28.45 M | ||||
| Shares Outstanding | 21.67 M | ||||
| Shares Owned By Insiders | 0.60 % | ||||
| Shares Owned By Institutions | 28.47 % | ||||
| Number Of Shares Shorted | 141.21 K | ||||
| Price To Earning | (0.31) X | ||||
| Price To Book | 0.91 X | ||||
| Gross Profit | (17.01 M) | ||||
| EBITDA | (15.61 M) | ||||
| Net Income | (15.73 M) | ||||
| Cash And Equivalents | 32.38 M | ||||
| Cash Per Share | 0.36 X | ||||
| Total Debt | 48 K | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 6.51 X | ||||
| Book Value Per Share | 1.41 X | ||||
| Cash Flow From Operations | (19.81 M) | ||||
| Short Ratio | 3.47 X | ||||
| Earnings Per Share | (2.88) X | ||||
| Target Price | 13.0 | ||||
| Number Of Employees | 15 | ||||
| Beta | 2.34 | ||||
| Market Capitalization | 45.72 M | ||||
| Total Asset | 106.01 M | ||||
| Retained Earnings | (288.52 M) | ||||
| Working Capital | 13.88 M | ||||
| Current Asset | 3.43 M | ||||
| Current Liabilities | 459 K | ||||
| Net Asset | 106.01 M |
About Aileron Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aileron Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aileron Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aileron Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Aileron Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aileron Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aileron Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Aileron Stock
Moving against Aileron Stock
| 0.88 | DRTS | Alpha Tau Medical | PairCorr |
| 0.87 | DMAC | DiaMedica Therapeutics | PairCorr |
| 0.79 | CDIOW | Cardio Diagnostics | PairCorr |
| 0.73 | VCYT | Veracyte Potential Growth | PairCorr |
| 0.66 | VCEL | Vericel Corp Ord | PairCorr |
The ability to find closely correlated positions to Aileron Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aileron Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aileron Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aileron Therapeutics to buy it.
The correlation of Aileron Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aileron Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aileron Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aileron Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aileron Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in Aileron Stock
If you are still planning to invest in Aileron Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aileron Therapeutics' history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |